Richard Gilbertson awarded Society of Memorial Sloan Kettering Prize

Professor Richard Gilbertson has been named the 2022 recipient of The Society of Memorial Sloan Kettering Prize. The Society Prize is a global recognition that is awarded annually to a researcher, physician, or team lead who has made a positive and lasting impact in the fight against pediatric cancer.

Professor Gilbertson was selected as this year’s recipient for the impact his contributions and discoveries have had on children with cancer. His research into the developmental origins of childhood brain tumors has led not only to an increased understanding of the molecular origins of these tumours, but has also impacted clinical outcomes through risk-stratified treatments and new targeted therapeutic options.

Dr Andrew Kung, Chair of the Department of Pediatrics at MSK Kids said “The Society of Memorial Sloan Kettering Prize recognizes individuals who have made extraordinary contributions to improving outcomes for children with cancer. Prof Gilbertson has made many significant discoveries over the years that have improved the way we as clinicians treat children with brain tumors. We are delighted to honor Prof Gilbertson and I can think of no one more deserving of joining the luminaries who have been honored with this Prize.”

Professor Gilbertson said “It is both exciting and humbling to be honoured with this recognition. I share this award with all my amazing colleagues and collaborators – including countless patients and their families – who together work daily to ensure cancer is no longer a leading cause of death by disease among children across the world.”